Ménière's Disease: Vertigo, Fluctuating Hearing Loss & the Signia Hearing Aid Response

Ménière's disease is an inner-ear disorder characterised by four core symptoms: episodic rotational vertigo lasting minutes to hours, sensorineural hearing loss (typically low-frequency and fluctuating in early stages), tinnitus in the affected ear, and a sensation of aural fullness. It affects approximately 1 in 1,000 adults, usually between 40 and 60 years of age, and is more common in women.

The underlying pathology is endolymphatic hydrops — an over-accumulation of fluid in the inner ear membranous labyrinth. Why this happens in some people is not fully understood; contributing factors include autoimmune inflammation, viral triggers, vascular dysfunction, and possibly genetic susceptibility. In India, Ménière's is often diagnosed late because early episodes are attributed to migraine, cervicogenic vertigo or benign paroxysmal positional vertigo (BPPV).

The American Academy of Otolaryngology–Head & Neck Surgery (AAO-HNS) 2015 diagnostic criteria — used by tertiary Indian ENT departments — define definite Ménière's as: two or more spontaneous episodes of vertigo, each lasting 20 minutes to 12 hours; audiometric documentation of low-to-medium frequency sensorineural loss in the affected ear on at least one occasion; and fluctuating aural symptoms (fullness, tinnitus, or hearing) in the affected ear.

Workup includes serial audiograms (essential — a single audiogram cannot confirm fluctuation), video-nystagmography (VNG), vestibular evoked myogenic potentials (VEMP), electrocochleography (ECochG), and MRI IAC with contrast to rule out vestibular schwannoma. A specialist neurotology referral is standard for definite cases.

First-line management is lifestyle: strict low-salt diet (under 2 g sodium daily), reduction of caffeine and alcohol, hydration, sleep regularity, and stress management. About 50–60% of patients achieve symptom control on lifestyle alone.

Pharmacological options include betahistine (widely used in India — Vertin, Vertistar, Betaserc — 24 mg twice daily is standard, though rigorous evidence is mixed), diuretics (hydrochlorothiazide plus potassium supplementation) for fluid load, and short courses of oral steroids during acute exacerbations. Vestibular sedatives (prochlorperazine, promethazine) are used sparingly and only during acute vertigo — they slow vestibular compensation if used long-term.

For refractory cases (10–20%), intratympanic dexamethasone injections are becoming the first invasive step in Delhi, Mumbai and Chennai tertiary ENT centres. Intratympanic gentamicin (chemical labyrinthectomy) and endolymphatic sac decompression surgery are reserved for the small minority who fail all other measures.

Ménière's audiograms are dynamic — a patient may show 45 dB low-frequency loss one week and near-normal thresholds the next. This defeats simple hearing aid prescriptions calibrated to a single audiogram. Modern Signia platforms handle this with adaptive fitting curves, multiple stored programs the wearer can switch between, and remote fine-tuning via the Signia app.

Our Ménière's-specific protocol at HearClear: audiograms at every symptomatic exacerbation for the first six months; a hearing aid fitted only after 3 months of relatively stable audiometry; three saved programs corresponding to typical loss states (mild, moderate, severe day); and monthly remote fine-tuning during the first year. Signia Kit Styletto 3IX and 5IX both handle this workload well because of their fine-grained WDRC and Own Voice Processing, which minimises the boom of low-frequency amplification during exacerbations.

For patients whose Ménière's has progressed to profound loss in the affected ear, a Signia CROS transmitter paired with a receiver aid on the better ear restores 360-degree awareness without amplifying the unstable side.

Ménière's disease is a chronic, fluctuating condition. Vertigo episodes typically become less frequent and severe after 5–10 years, but hearing loss usually stabilises at moderate-to-severe levels in the affected ear. Some patients develop bilateral involvement — a specific poorer-prognosis subset that needs closer surveillance.

Emotional support matters. Sudden vertigo attacks are frightening, career-limiting for high-attention jobs (driving, surgery, machinery), and often produce secondary anxiety. Vestibular rehabilitation therapy, delivered by physiotherapists trained in vestibular protocols, reduces disability meaningfully. Cognitive-behavioural therapy (CBT) for anxiety-vertigo cycles is under-utilised in India — worth requesting.

If any of the above matches your experience, book a free clinical hearing assessment. Our Signia Certified audiologists are RCI-registered and offer home visits across 195+ Indian cities — the audiogram is diagnostic and always free.

This article is a plain-language summary reviewed against ASHA (American Speech-Language-Hearing Association), IJOHNS (Indian Journal of Otolaryngology and Head & Neck Surgery), BSA (British Society of Audiology) and Signia clinical documentation. It is educational only. Any concerning symptoms warrant an in-person evaluation by an ENT physician and an RCI-registered audiologist.